0

Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients With Systemic Sclerosis

Tobias C Messemaker, Loubna Chadli, Guoshuai Cai, Varshna S Goelela, Maaike Boonstra, Annemarie L Dorjée, Stefan N Andersen, Harald M M Mikkers, Peter van 't Hof, Hailiang Mei, Oliver Distler, Harmen H M Draisma, etc.

J Invest Dermatol. 2018 Apr;138(4):826-835.

PMID: 29179949

Abstract:

Systemic sclerosis is an autoimmune disease characterized by fibrosis of skin and multiple organs of which the pathogenesis is poorly understood. We studied differentially expressed coding and non-coding genes in relation to systemic sclerosis pathogenesis with a specific focus on antisense non-coding RNAs. Skin biopsy-derived RNAs from 14 early systemic sclerosis patients and six healthy individuals were sequenced with ion-torrent and analyzed using DEseq2. Overall, 4,901 genes with a fold change >1.5 and a false discovery rate <5% were detected in patients versus controls. Upregulated genes clustered in immunologic, cell adhesion, and keratin-related processes. Interestingly, 676 deregulated non-coding genes were detected, 257 of which were classified as antisense genes. Sense genes expressed opposite of these antisense genes were also deregulated in 42% of the observed sense-antisense gene pairs. The majority of the antisense genes had a similar effect sizes in an independent North American dataset with three genes (CTBP1-AS2, OTUD6B-AS1, and AGAP2-AS1) exceeding the study-wide Bonferroni-corrected P-value (PBonf < 0.0023, Pcombined = 1.1 × 10-9, 1.4 × 10-8, 1.7 × 10-6, respectively). In this study, we highlight that together with coding genes, (antisense) long non-coding RNAs are deregulated in skin tissue of systemic sclerosis patients suggesting a novel class of genes involved in pathogenesis of systemic sclerosis.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR42415053 OTUD6B active human OTUD6B active human Price
qrcode